As guaranteed by the Centers for Medicare & Medicaid Services (CMS) in late-2015, the Federally-Facilitated Marketplaces (FFMs) have actually begun sending notifications notifying companies that workers have registered in a FFM and were determined eligible for premium subsidies. Because the employer shared obligation penalties set forth in Section 4980H of the Internal Revenue Code (the "Code") might be set off when at least one full-time employee obtains a premium subsidy on the Marketplace, an employer receiving one of these notices must understandably be concerned about the possibility of charges. However, these notices do not ensure that a penalty will be assessed. Here's what companies need to know:
United States: Marketplace Subsidy Notices What Companies Need to Know
German eyewear marketplace Brillen.de scores $49 million from previous Facebook and Netflix financiers
Germany-based Brillen.de revealed a huge financing round Thursday with 45 million ($ 49 million) from simply one investor: Technology Crossover Ventures (TCV).
A normal independent optometrist draws in just a few consumers in their store per day, Brillen.de Co-Founder Daniel Thung informed TechCrunch. On average we double their customers per day.
Brillen.de, a subsidiary of SuperVista AG, already has extended its company across the border to Austria, including pressing its brands specsfactory.co.uk and the Spanish gafas.es to the Austrian market. Further Deatils are available at https://gigleague.com/.
Google's new NHS offer is start of artificial intelligence market
DeepMind, Google’s London-based artificial intelligence company, has actually started training neural networks to identify the indications of eye illness in medical images. A partnership with Moorfields Eye Hospital in London has actually given the company access to about a million anonymized retinal scans, which DeepMind will feed into its artificial intelligence software.
The project will target two of the most typical eye diseases age associated macular degeneration and diabetic retinopathy. More than 100 million people around the globe have these conditions.